Moderna, Inc. (MRNA) vs Vertex Pharmaceuticals Incorporated (VRTX)
Moderna, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $78.8B — 1.7× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Vertex Pharmaceuticals Incorporated trades at 30.4×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.2% against −27.6%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs −141.4%) and the higher return on invested capital (24.1% vs −93.5%). Across the 19 metrics below, Vertex Pharmaceuticals Incorporated leads on 18 and Moderna, Inc. on 1.
Valuation
Profitability
| Metric | MRNA | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 23.38% | 86.00% | 65.16% |
| Operating margin | (149.01%) | 37.95% | 0.00% |
| Net margin | (141.43%) | 35.00% | 0.00% |
| Free cash flow margin | (55.83%) | 30.16% | 0.00% |
| Return on equity | (39.00%) | 23.54% | (57.72%) |
| Return on assets | (27.43%) | 17.12% | (49.22%) |
| Return on invested capital | (93.47%) | 24.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack